The MTT assay showed that the proliferation capacity of gastric cancer cells infected with AdMax-pDC315-DRAM-EGFP was significant1y higher than AdMax-pDC315-EGFP (MOI, 60) (P<0.05). This evidence concerns the gene DRAM1 and gastric cancer.